These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23938141)

  • 1. PET and PET-CT imaging findings of peritoneal and omental involvement in patients with lymphoma.
    Karaosmanoglu AD; Butros SR; Scott J; Blake MA
    Clin Imaging; 2013; 37(6):1089-93. PubMed ID: 23938141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT findings of lymphoma with peritoneal, omental and mesenteric involvement: peritoneal lymphomatosis.
    Karaosmanoglu D; Karcaaltincaba M; Oguz B; Akata D; Ozmen M; Akhan O
    Eur J Radiol; 2009 Aug; 71(2):313-7. PubMed ID: 18513906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG uptake in diffuse peritoneal lymphomatosis.
    Yapar AF; Reyhan M
    Clin Nucl Med; 2012 Jul; 37(7):e176-7. PubMed ID: 22691529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET/CT findings of peritoneal lymphomatosis.
    Kaneko K; Masunari S; Yoshida T; Omagari J
    Clin Nucl Med; 2012 Nov; 37(11):1117-9. PubMed ID: 22996239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in CT features of peritoneal carcinomatosis, sarcomatosis, and lymphomatosis: retrospective analysis of 122 cases at a tertiary cancer institution.
    O'Neill AC; Shinagare AB; Rosenthal MH; Tirumani SH; Jagannathan JP; Ramaiya NH
    Clin Radiol; 2014 Dec; 69(12):1219-27. PubMed ID: 25308238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis.
    Cabral FC; Krajewski KM; Kim KW; Ramaiya NH; Jagannathan JP
    Cancer Imaging; 2013 Apr; 13(2):162-70. PubMed ID: 23598428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenteric panniculitis in oncologic patients: PET-CT findings.
    Zissin R; Metser U; Hain D; Even-Sapir E
    Br J Radiol; 2006 Jan; 79(937):37-43. PubMed ID: 16421403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A child with Burkitt lymphoma with pleural, peritoneal, mesenteric, omental, and renal involvement: diagnostics by FDG PET/CT.
    Wang X; Chen Z; Tang G; Zhang X
    Clin Nucl Med; 2011 Jul; 36(7):612-5. PubMed ID: 21637077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.
    Anthony MP; Khong PL; Zhang J
    AJR Am J Roentgenol; 2009 Dec; 193(6):W523-9. PubMed ID: 19933627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
    Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
    Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal lymphomatosis mimicking peritoneal carcinomatosis: important imaging clues for correct diagnosis.
    Sia DS; Kapur J; Thian YL
    Singapore Med J; 2013 Apr; 54(4):e93-6. PubMed ID: 23624464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare involvement of diffuse large B-cell lymphoma: Peritoneal lymphomatosis with a peritoneal super-scan appearance on
    Yılmaz F; Önner H
    Hell J Nucl Med; 2022; 25(1):103-105. PubMed ID: 35388807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal lymphomatosis: CT findings.
    Kim Y; Cho O; Song S; Lee H; Rhim H; Koh B
    Abdom Imaging; 1998; 23(1):87-90. PubMed ID: 9437071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
    Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
    Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing omental PET/CT findings for differentiating tuberculous peritonitis from peritoneal carcinomatosis.
    Duan H; Xu D; Lu R; Wang S; Xie R; Wang S
    Abdom Radiol (NY); 2021 Dec; 46(12):5574-5585. PubMed ID: 34549331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT.
    Puranik AD; Purandare NC; Agrawal A; Shah S; Rangarajan V
    Jpn J Radiol; 2014 Oct; 32(10):571-8. PubMed ID: 25120221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT manifestations of peritoneal carcinomatosis.
    Walkey MM; Friedman AC; Sohotra P; Radecki PD
    AJR Am J Roentgenol; 1988 May; 150(5):1035-41. PubMed ID: 3258703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.